Home › Trial NCT04275583
A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3602 Capsule
- Trial IDNCT04275583
- StatusUnknown
- PhasePhase 1
- Study typeInterventional
- SponsorChia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Enrollment40
- Start date2020-05-28
- ConditionsMultiple Myeloma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Human verification coming soon — the enriched analysis will be viewable here.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.